skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Academic Search Premier remover assunto: Male remover Leukemia & Lymphoma remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 2 study of the BH3 mimetic BCL2 inhibitor navitoclax (ABT-263) with or without rituximab, in previously untreated B-cell chronic lymphocytic leukemia

Kipps, Thomas J ; Eradat, Herbert ; Grosicki, Sebastian ; Catalano, John ; Cosolo, Walter ; Dyagil, Iryna S ; Yalamanchili, Sreeni ; Chai, Akiko ; Sahasranaman, Srikumar ; Punnoose, Elizabeth ; Hurst, Deborah ; Pylypenko, Halyna

Leukemia & lymphoma, 2015-10, Vol.56 (10), p.2826-2833 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
2
Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group
Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group

Goede, Valentin ; Bahlo, Jasmin ; Chataline, Viktoria ; Eichhorst, Barbara ; Dürig, Jan ; Stilgenbauer, Stephan ; Kolb, Gerald ; Honecker, Friedemann ; Wedding, Ulrich ; Hallek, Michael

Leukemia & lymphoma, 2016-04, Vol.57 (4), p.789-796 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
3
Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database
Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database

Rajyaguru, Devalkumar J. ; Bhaskar, Chaithanya ; Borgert, Andrew J. ; Smith, Angela ; Parsons, Benjamin

Leukemia & lymphoma, 2017-09, Vol.58 (9), p.2080-2088 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
4
MYC protein expression is an important prognostic factor in acute myeloid leukemia
MYC protein expression is an important prognostic factor in acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

MYC protein expression is an important prognostic factor in acute myeloid leukemia

Ohanian, Maro ; Rozovski, Uri ; Kanagal-Shamanna, Rashmi ; Abruzzo, Lynne V. ; Loghavi, Sanam ; Kadia, Tapan ; Futreal, Andrew ; Bhalla, Kapil ; Zuo, Zhuang ; Huh, Yang O. ; Post, Sean M. ; Ruvolo, Peter ; Garcia-Manero, Guillermo ; Andreeff, Michael ; Kornblau, Steven ; Borthakur, Gautam ; Hu, Peter ; Medeiros, L. Jeffrey ; Takahashi, Koichi ; Hornbaker, Marisa J. ; Zhang, Jianhua ; Nogueras-González, Graciela M. ; Huang, Xuelin ; Verstovsek, Srdan ; Estrov, Zeev ; Pierce, Sherry ; Ravandi, Farhad ; Kantarjian, Hagop M. ; Bueso-Ramos, Carlos E. ; Cortes, Jorge E.

Leukemia & lymphoma, 2019-01, Vol.60 (1), p.37-48 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
5
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia
Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia

De Luca, Luciana ; D'Arena, Giovanni ; Simeon, Vittorio ; Trino, Stefania ; Laurenzana, Ilaria ; Caivano, Antonella ; La Rocca, Francesco ; Villani, Oreste ; Mansueto, Giovanna ; Deaglio, Silvia ; Innocenti, Idanna ; Laurenti, Luca ; Molica, Stefano ; Pietrantuono, Giuseppe ; De Stradis, Angelo ; Del Vecchio, Luigi ; Musto, Pellegrino

Leukemia & lymphoma, 2017-06, Vol.58 (6), p.1424-1432 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
6
A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia
A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia

Dasgupta, Alakananda ; Mahapatra, Manoranjan ; Saxena, Renu

Leukemia & lymphoma, 2015-06, Vol.56 (6), p.1831-1838 [Periódico revisado por pares]

United States: Informa Healthcare

Texto completo disponível

Citações Citado por
7
Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma
Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma

Vogl, Dan T. ; Martin, Thomas G. ; Vij, Ravi ; Hari, Parameswaran ; Mikhael, Joseph R. ; Siegel, David ; Wu, Ka Lung ; Delforge, Michel ; Gasparetto, Cristina

Leukemia & lymphoma, 2017-08, Vol.58 (8), p.1872-1879 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
8
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies

Wu, Yaogong ; Chen, Wenlan ; Li, Wenjing ; Zhao, Miaomiao ; Wei, Qiuzhe ; Zhang, Xiaoping ; Mei, Heng ; Wang, Yadan ; Hu, Yu

Leukemia & lymphoma, 2020-12, Vol.61 (14), p.3440-3450 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
9
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma

Niesvizky, Ruben ; Badros, Ashraf Z ; Costa, Luciano J ; Ely, Scott A ; Singhal, Seema B ; Stadtmauer, Edward A ; Haideri, Nisreen A ; Yacoub, Abdulraheem ; Hess, Georg ; Lentzsch, Suzanne ; Spicka, Ivan ; Chanan-Khan, Asher A ; Raab, Marc S ; Tarantolo, Stefano ; Vij, Ravi ; Zonder, Jeffrey A ; Huang, Xiangao ; Jayabalan, David ; Di Liberto, Maurizio ; Huang, Xin ; Jiang, Yuqiu ; Kim, Sindy T ; Randolph, Sophia ; Chen-Kiang, Selina

Leukemia & lymphoma, 2015-12, Vol.56 (12), p.3320-3328 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
10
Risk factors for the development of atrial fibrillation on ibrutinib treatment
Risk factors for the development of atrial fibrillation on ibrutinib treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Risk factors for the development of atrial fibrillation on ibrutinib treatment

Lentz, Robert ; Feinglass, Joseph ; Ma, Shuo ; Akhter, Nausheen

Leukemia & lymphoma, 2019-05, Vol.60 (6), p.1447-1453 [Periódico revisado por pares]

United States: Taylor & Francis

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2009  (2)
  2. 2009Até2010  (13)
  3. 2011Até2012  (52)
  4. 2013Até2015  (67)
  5. Após 2015  (88)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.